Atom Investors LP United Therapeutics Corp Transaction History

Atom Investors LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $607,465 - $726,369	2,827 Added 100.18%	5,649 $1.24 Million
Q3 2023 Nov 14, 2023	BUY	$211.82 - $248.24 $597,756 - $700,533	2,822 New	2,822 $637,000
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $432,182 - $556,509	-2,601 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $479,416 - $562,024	2,601 New	2,601 $562,000
Q2 2021 Aug 16, 2021	SELL	$170.47 - $211.93 $690,233 - $858,104	-4,049 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$153.94 - $174.85 $1.09 Million - $1.24 Million	-7,110 Reduced 63.72%	4,049 $677,000
Q4 2020 Feb 16, 2021	BUY	$101.87 - $151.79 $1.14 Million - $1.69 Million	11,159 New	11,159 $1.69 Million
Q3 2020 Nov 13, 2020	SELL	$99.9 - $121.13 $2 Million - $2.43 Million	-20,020 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$92.74 - $125.82 $14.6 Million - $19.9 Million	-157,941 Reduced 88.75%	20,020 $2.42 Million
Q1 2020 May 15, 2020	BUY	$79.39 - $115.35 $1.93 Million - $2.8 Million	24,255 Added 15.78%	177,961 $16.9 Million
Q4 2019 Feb 13, 2020	SELL	$78.31 - $95.34 $1.5 Million - $1.83 Million	-19,187 Reduced 11.1%	153,706 $13.5 Million
Q3 2019 Nov 14, 2019	BUY	$74.85 - $85.99 $9.84 Million - $11.3 Million	131,415 Added 316.83%	172,893 $13.8 Million
Q2 2019 Aug 14, 2019	BUY	$76.06 - $120.81 $2.72 Million - $4.32 Million	35,738 Added 622.61%	41,478 $3.24 Million
Q1 2019 May 15, 2019	BUY	$107.15 - $126.84 $268,517 - $317,861	2,506 Added 77.49%	5,740 $674,000
Q4 2018 Feb 14, 2019	BUY	$101.4 - $128.73 $327,927 - $416,312	3,234 New	3,234 $352,000

673

42.2M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.